Supplementary Figure 2 from Adaptive Dosing Approaches to the Individualization of 13-&Lt;i>cis</i>-retinoic Acid (isotretinoin) Treatment for Children with High-Risk Neuroblastoma

Gareth J. Veal,Julie Errington, Sophie E. Rowbotham,Nicola A. Illingworth,Ghada Malik,Michael Cole,Ann K. Daly,Andrew D.J. Pearson,Alan V. Boddy

openalex（2023）

引用 0|浏览0

暂无评分

摘要

PDF file - 43K, Relationship between 13-cisRA AUC0-6h and 13-cisRA Cmax determined from pharmacokinetic profiles obtained following protocol-based 13-cisRA dosing (n=103)

查看译文

关键词

Differentiation Therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Figure 2 from Adaptive Dosing Approaches to the Individualization of 13-&Lt;i&gt;cis&lt;/i&gt;-retinoic Acid (isotretinoin) Treatment for Children with High-Risk Neuroblastoma

Supplementary Figure 2 from Adaptive Dosing Approaches to the Individualization of 13-&Lt;i>cis</i>-retinoic Acid (isotretinoin) Treatment for Children with High-Risk Neuroblastoma